Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.

Kramann R, Brandenburg VM, Schurgers LJ, Ketteler M, Westphal S, Leisten I, Bovi M, Jahnen-Dechent W, Knüchel R, Floege J, Schneider RK.

Nephrol Dial Transplant. 2013 Apr;28(4):856-68. doi: 10.1093/ndt/gfs466. Epub 2012 Dec 6.

PMID:
23223222
2.

Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells.

Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM.

Am J Kidney Dis. 2001 Jun;37(6):1267-76.

PMID:
11382698
3.

Uraemia disrupts the vascular niche in a 3D co-culture system of human mesenchymal stem cells and endothelial cells.

Kramann R, Couson SK, Neuss S, Floege J, Knüchel R, Schneider RK.

Nephrol Dial Transplant. 2012 Jul;27(7):2693-702. doi: 10.1093/ndt/gfr656. Epub 2011 Dec 29.

PMID:
22207324
4.

Cutaneous necrosis from calcific uremic arteriolopathy.

Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP.

Am J Kidney Dis. 1998 Sep;32(3):384-91. Review.

PMID:
9740153
5.

Calciphylaxis in the current era: emerging 'ironic' features?

Farah M, Crawford RI, Levin A, Chan Yan C.

Nephrol Dial Transplant. 2011 Jan;26(1):191-5. doi: 10.1093/ndt/gfq407. Epub 2010 Jul 12.

PMID:
20627865
6.

Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis.

Griethe W, Schmitt R, Jurgensen JS, Bachmann S, Eckardt KU, Schindler R.

J Nephrol. 2003 Sep-Oct;16(5):728-32.

PMID:
14733421
7.

Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Brandenburg VM, Sinha S, Specht P, Ketteler M.

Pediatr Nephrol. 2014 Dec;29(12):2289-98. doi: 10.1007/s00467-013-2746-7. Epub 2014 Jan 29. Review.

PMID:
24474577
8.

Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.

Kramann R, Kunter U, Brandenburg VM, Leisten I, Ehling J, Klinkhammer BM, Knüchel R, Floege J, Schneider RK.

J Bone Miner Res. 2013 Dec;28(12):2523-34. doi: 10.1002/jbmr.1994.

9.

Metal deposition in calcific uremic arteriolopathy.

Amuluru L, High W, Hiatt KM, Ranville J, Shah SV, Malik B, Swaminathan S.

J Am Acad Dermatol. 2009 Jul;61(1):73-9. doi: 10.1016/j.jaad.2009.01.042. Epub 2009 Apr 29.

10.

Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Sowers KM, Hayden MR.

Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354. Review.

11.

Quantitative determination of matrix Gla protein (MGP) and BMP-2 during the osteogenic differentiation of human periodontal ligament cells.

Li R, Li X, Zhou M, Han N, Zhang Q.

Arch Oral Biol. 2012 Oct;57(10):1408-17. doi: 10.1016/j.archoralbio.2012.07.005. Epub 2012 Aug 4.

PMID:
22871356
12.

Calcific uraemic arteriolopathy: an update.

Rogers NM, Coates PT.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):629-34. doi: 10.1097/MNH.0b013e32830f4566. Review.

PMID:
18941358
13.

Healing of skin necrosis and regression of anticardiolipin antibodies achieved by parathyroidectomy in a dialyzed woman with calcific uremic arteriolopathy.

Sefer S, Trotić R, Degoricija V, Vrsalović M, Ratković-Gusić I, Kes P.

Croat Med J. 2001 Dec;42(6):679-82.

14.

Calciphylaxis causing digital, gangrene in end stage renal disease: a case report and review.

Sanusi AA, Arogundade FA, Udo AI, Hassan MO, Oyewole O, Kolawole T, Akinsola A.

West Afr J Med. 2013 Jan-Mar;32(1):68-72. Review.

PMID:
23613298
15.

Multidisciplinary approach to calcific uremic arteriolopathy.

Nigwekar SU.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):531-7. doi: 10.1097/MNH.0000000000000175. Review.

PMID:
26371529
16.

Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells.

Kramann R, Couson SK, Neuss S, Kunter U, Bovi M, Bornemann J, Knüchel R, Jahnen-Dechent W, Floege J, Schneider RK.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):e45-54. doi: 10.1161/ATVBAHA.111.228601. Epub 2011 Jun 16.

17.

Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series.

Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A.

J Nephrol. 2002 Nov-Dec;15(6):676-80.

PMID:
12495283
18.

Involvement of parathyroid hormone-related protein in vascular calcification of chronic haemodialysis patients.

Liu F, Fu P, Fan W, Gou R, Huang Y, Qiu H, Zhong H, Huang S.

Nephrology (Carlton). 2012 Aug;17(6):552-60. doi: 10.1111/j.1440-1797.2012.01601.x.

PMID:
22448974
19.

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet).

Brandenburg V, Adragao T, van Dam B, Evenepoel P, Frazão JM, Ketteler M, Mazzaferro S, Urena Torres P, Ramos R, Torregrosa JV, Cozzolino M.

Clin Kidney J. 2015 Oct;8(5):567-71. doi: 10.1093/ckj/sfv056. Epub 2015 Jul 6. Review.

20.

Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure.

Janigan DT, Hirsch DJ, Klassen GA, MacDonald AS.

Am J Kidney Dis. 2000 Apr;35(4):588-97. Review.

PMID:
10739777

Supplemental Content

Support Center